Co-Authors
This is a "connection" page, showing publications co-authored by Gregg Stone and Behnood Bikdeli.
Connection Strength
2.062
-
Bivalirudin bewilderment. Kardiol Pol. 2018; 76(4):711-712.
Score: 0.749
-
Effect of Intermediate-Dose vs Standard-Dose Prophylactic Anticoagulation on Thrombotic Events, Extracorporeal Membrane Oxygenation Treatment, or Mortality Among Patients With COVID-19 Admitted to the Intensive Care Unit: The INSPIRATION Randomized Clinical Trial. JAMA. 2021 04 27; 325(16):1620-1630.
Score: 0.236
-
Intermediate-Dose versus Standard-Dose Prophylactic Anticoagulation in Patients with COVID-19 Admitted to the Intensive Care Unit: 90-Day Results from the INSPIRATION Randomized Trial. Thromb Haemost. 2022 Jan; 122(1):131-141.
Score: 0.235
-
Recent Randomized Trials of Antithrombotic Therapy for Patients With COVID-19: JACC State-of-the-Art Review. J Am Coll Cardiol. 2021 04 20; 77(15):1903-1921.
Score: 0.234
-
Pharmacological Agents Targeting Thromboinflammation in COVID-19: Review and Implications for Future Research. Thromb Haemost. 2020 Jul; 120(7):1004-1024.
Score: 0.221
-
COVID-19 and Thrombotic or Thromboembolic Disease: Implications for Prevention, Antithrombotic Therapy, and Follow-Up: JACC State-of-the-Art Review. J Am Coll Cardiol. 2020 06 16; 75(23):2950-2973.
Score: 0.219
-
Association between antecedent statin use and decreased mortality in hospitalized patients with COVID-19. Nat Commun. 2021 02 26; 12(1):1325.
Score: 0.058
-
Extrapulmonary manifestations of COVID-19. Nat Med. 2020 07; 26(7):1017-1032.
Score: 0.056
-
Cardiovascular Considerations for Patients, Health Care Workers, and Health Systems During the COVID-19 Pandemic. J Am Coll Cardiol. 2020 05 12; 75(18):2352-2371.
Score: 0.055